Results 21 to 30 of about 75,798 (257)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Potentiation of antimicrobial activity of colistin with antibiotics of different groups against multidrug- and extensively drug-resistant strains of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия, 2020
Objective. To reveal antibiotics being capable of potentiating the antimicrobial activity of colistin against multidrug- and extensively drug-resistant strains of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa. Materials and
Tapalskiy D.V.   +3 more
doaj   +1 more source

Risk factors for Haemophilus influenzae and pneumococcal respiratory tract colonization in CVID [PDF]

open access: yes, 2018
To the Editor: Disease-specific studies focused on infection risk in common variable immune deficiencies (CVIDs) are needed to define strategies for controlling respiratory infections predominantly due to bacteria such as Streptococcus pneumoniae and ...
Camilli, Romina   +10 more
core   +1 more source

Macrolide Therapy in Respiratory Viral Infections

open access: yesMediators of Inflammation, 2012
Background. Macrolides have received considerable attention for their anti-inflammatory and immunomodulatory actions beyond the antibacterial effect. These two properties may ensure some efficacy in a wide spectrum of respiratory viral infections.
Jin-Young Min, Yong Ju Jang
doaj   +1 more source

Familial Occurrence of Mycoplasma-induced Rash and Mucositis: A Case Report of Two Siblings [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Mycoplasma pneumoniae is a common pathogen responsible for respiratory infections, including community-acquired pneumonia, and up to 25% of patients develop extrapulmonary complications.
Roja Aepala   +4 more
doaj   +1 more source

Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma [PDF]

open access: yes, 2017
Background: This study of the oropharyngeal microbiome complements the previously published AZIthromycin in Severe ASThma (AZISAST) clinical trial, where the use of azithromycin was assessed in subjects with exacerbationprone severe asthma.
Brusselle, Guy   +9 more
core   +1 more source

Persistence of Resistant Staphylococcus epidermidis after Single Course of Clarithromycin

open access: yesEmerging Infectious Diseases, 2005
We examined how a common therapy that includes clarithromycin affects normally colonizing Staphylococcus epidermidis. Samples from the nostrils of 5 patients receiving therapy were collected before, immediately after, 1 year after, and 4 years after ...
Maria Sjölund   +4 more
doaj   +1 more source

Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease

open access: yesTherapeutic Advances in Respiratory Disease, 2017
Chronic inflammation plays a central role in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, there are no effective anti-inflammatory pharmacologic therapies available for COPD so far.
Shilin Qiu, Xiaoning Zhong
doaj   +1 more source

Community-acquired pneumonia: antibiotic therapy approach after the COVID-19 pandemic. A review

open access: yesConsilium Medicum, 2023
Pneumonia is clearly differentiated from other focal inflammatory lung diseases of non-infectious origin. A patient with community-acquired pneumonia (CAP) should receive antibacterial drugs no later than 4 hours after the diagnosis.
Andrey A. Zaytsev, Igor A. Guchev
doaj   +1 more source

Conjugative transfer frequencies of mef(A)-containing Tn1207.3 to macrolide-susceptible Streptococcus pyogenes belonging to different emm types [PDF]

open access: yes, 2014
The aim of this study was to examine the gene transfer potential of mef(A)-containing Tn120.3 to macrolide-susceptible Streptococcus pyogenes belonging to different emm types.
Hadjirin, N. F.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy